Cargando…

Vascular endothelial growth factor gene polymorphisms and association with age related macular degeneration in Indian patients

BACKGROUND: Age-related macular degeneration (AMD) is an important cause of visual impairment in elderly people. AMD is a multifactorial disease in which both environmental and genetic factors have been implicated. Various single nucleotide polymorphisms (SNPs) have been found to be associated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Divya, Gupta, Vani, Singh, Vinita, Prakash, Swayam, Agrawal, Suraksha, Chawla, Shobhit, Phadke, Shubha R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006127/ https://www.ncbi.nlm.nih.gov/pubmed/27617226 http://dx.doi.org/10.1016/j.mgene.2016.07.011

Ejemplares similares

Vascular Endothelial Growth Factor Gene Polymorphism Is Associated With Long-term Kidney Allograft Outcomes
por: Prakash, Swayam, et al.
Publicado: (2017)

Cytochrome P450 (CYP2C9*2,*3) & vitamin-K epoxide reductase complex (VKORC1 -1639G<A) gene polymorphisms & their effect on acenocoumarol dose in patients with mechanical heart valve replacement
por: Kaur, Anupriya, et al.
Publicado: (2013)

Association between CFH Y402H Polymorphism and Age Related Macular Degeneration in North Indian Cohort
por: Sharma, Neel Kamal, et al.
Publicado: (2013)

The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degeneration
por: Azad, Rajvardhan, et al.
Publicado: (2007)

Vascular endothelial growth factor genetic polymorphisms and susceptibility to age-related macular degeneration in Tunisian population
por: Habibi, Imen, et al.
Publicado: (2014)

Vascular endothelial growth factor genetic polymorphisms and susceptibility to age-related macular degeneration in Tunisian population
por: Habibi, Imen, et al.
Publicado: (2012)

Superoxide Dismutase1 Levels in North Indian Population with Age-Related Macular Degeneration
por: Anand, Akshay, et al.
Publicado: (2013)

Association between Vascular Endothelial Growth Factor Polymorphisms and Age-Related Macular Degeneration: An Updated Meta-Analysis
por: Barchitta, Martina, et al.
Publicado: (2016)

Vascular endothelial growth factor A polymorphisms and age-related macular degeneration: a systematic review and meta-analysis
por: Huang, Chen, et al.
Publicado: (2013)

Exploring the role of VEGF in Indian Age related macular degeneration
por: Sharma, Kaushal, et al.
Publicado: (2015)

Factors affecting compliance to intravitreal anti-vascular endothelial growth factor therapy in Indian patients with retinal vein occlusion, age-related macular degeneration, and diabetic macular edema
por: Kelkar, Aditya, et al.
Publicado: (2020)

Single Nucleotide Polymorphisms in MCP-1 and Its Receptor Are Associated with the Risk of Age Related Macular Degeneration
por: Anand, Akshay, et al.
Publicado: (2012)

Vascular Response to Sildenafil Citrate in Aging and Age-Related Macular Degeneration
por: Yiu, Glenn, et al.
Publicado: (2019)

Macular Atrophy Development and Subretinal Drusenoid Deposits in Anti-Vascular Endothelial Growth Factor Treated Age-Related Macular Degeneration
por: Zarubina, Anna V., et al.
Publicado: (2017)

Prenatal screening for genetic disorders: Suggested guidelines for the Indian Scenario
por: Phadke, Shubha R., et al.
Publicado: (2017)

Association of obesity and age-related macular degeneration in Indian population
por: Jaisankar, Durgasri, et al.
Publicado: (2018)

Characterization of age-related macular degeneration in Indian donor eyes
por: Soundara Pandi, Sudha Priya, et al.
Publicado: (2021)

Brain Abscess Risk Associated with Genotypic Polymorphism of the Matrix Metalloproteinase-1, -2, -3, and -9 in North Indian Population
por: Mishra, Priyanka, et al.
Publicado: (2017)

Anti-vascular endothelial growth factor in age-related macular degeneration: Puzzle or a silent beginning!
por: Natarajan, Sundaram
Publicado: (2013)

Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration
por: Hussain, Rehan M, et al.
Publicado: (2021)

Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhage
por: Maruyama-Inoue, Maiko, et al.
Publicado: (2023)

Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
por: Bhagat, Davis, et al.
Publicado: (2020)

Interleukin-1 Gene Cluster Polymorphisms and Their Association with Coronary Artery Disease: Separate Evidences from the Largest Case-Control Study amongst North Indians and an Updated Meta-Analysis
por: Rai, Himanshu, et al.
Publicado: (2016)

Comment on: Association of obesity and age-related macular degeneration in Indian population
por: Takkar, Brijesh
Publicado: (2019)

Changing trends in the use of anti-vascular endothelial growth factor (anti-VEGF) biosimilars: Insights from the Vitreoretinal Society of India Biosimilars of Anti-VEGF Survey
por: Sheth, Jay U, et al.
Publicado: (2021)

Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration
por: Kim, Ramasamy
Publicado: (2007)

Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
por: Wingard, Jeremy B, et al.
Publicado: (2019)

Ten-year outcome of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration
por: Upasani, Deepa, et al.
Publicado: (2021)

Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration
por: Hanhart, Joel, et al.
Publicado: (2022)

Evaluation of vascular endothelial growth factor (VEGF) level in the tears and serum of age-related macular degeneration patients
por: Shahidatul-Adha, Mohamad, et al.
Publicado: (2022)

Twenty Years of Anti-Vascular Endothelial Growth Factor Therapeutics in Neovascular Age-Related Macular Degeneration Treatment
por: Moon, Bo-Hyun, et al.
Publicado: (2023)

Aflibercept: a Potent Vascular Endothelial Growth Factor Antagonist for Neovascular Age-Related Macular Degeneration and Other Retinal Vascular Diseases
por: Sophie, Raafay, et al.
Publicado: (2012)

Efficacy of low-vision devices in elderly population with age-related macular degeneration
por: Singh, Kirti, et al.
Publicado: (2023)

Omega-3 Supplementation Combined With Anti–Vascular Endothelial Growth Factor Lowers Vitreal Levels of Vascular Endothelial Growth Factor in Wet Age-Related Macular Degeneration
por: REZENDE, FLAVIO A., et al.
Publicado: (2014)

Choroidal Vascular Impairment in Intermediate Age-Related Macular Degeneration
por: Flores, Rita, et al.
Publicado: (2022)

Response to comment on: Association of obesity and age-related macular degeneration in Indian population
por: Jaisankar, Durgasri, et al.
Publicado: (2019)

Outcome of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration in real-life setting
por: Kataja, Maria, et al.
Publicado: (2018)

Factors Affecting Compliance to Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Age-Related Macular Degeneration
por: Polat, Onur, et al.
Publicado: (2017)

Laser and anti-vascular endothelial growth factor treatment for drusenoid pigment epithelial detachment in age-related macular degeneration
por: Kim, Min Seok, et al.
Publicado: (2020)

Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment
por: Mantel, Irmela, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kqd50j5f3mchtbkl93ear52lr3